Literature DB >> 24395292

Endothelial nitric oxide synthase polymorphisms and haplotypes in genetic epidemiology and pharmacogenetics: remarks regarding a lack of association on the risk of myocardial infarction.

Marcelo Rizzatti Luizon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24395292     DOI： 10.1007/s11033-013-2928-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN： 0301-4851            Impact factor:   2.316


× No keyword cloud information.
  20 in total

1.  Endothelial nitric oxide synthase polymorphism rs3918226 associated with hypertension does not affect plasma nitrite levels in healthy subjects.

Authors:  Marcelo R Luizon; Ingrid F Metzger; Riccardo Lacchini; Jose E Tanus-Santos
Journal:  Hypertension       Date:  2012-04-30       Impact factor: 10.190

2.  Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction.

Authors:  J J Muniz; R Lacchini; T O Rinaldi; Y T D A Nobre; A J Cologna; A C P Martins; J E Tanus-Santos
Journal:  Pharmacogenomics J       Date:  2011-11-08       Impact factor: 3.550

Review 3.  Definition and clinical importance of haplotypes.

Authors:  Dana C Crawford; Deborah A Nickerson
Journal:  Annu Rev Med       Date:  2005       Impact factor: 13.739

4.  Haplotype analysis can provide improved clinical information than single genotype analysis.

Authors:  Valeria Cristina Sandrim; Jose Eduardo Tanus-Santos
Journal:  Thromb Res       Date:  2006-12-14       Impact factor: 3.944

5.  Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms.

Authors:  Aline S Marroni; Ingrid F Metzger; Debora C Souza-Costa; Sabrina Nagassaki; Valeria C Sandrim; Ronan X Correa; Fabricio Rios-Santos; Jose E Tanus-Santos
Journal:  Nitric Oxide       Date:  2005-05       Impact factor: 4.427

Review 6.  Pharmacogenomics knowledge for personalized medicine.

Authors:  M Whirl-Carrillo; E M McDonagh; J M Hebert; L Gong; K Sangkuhl; C F Thorn; R B Altman; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2012-10       Impact factor: 6.875

7.  Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus.

Authors:  Valéria C Sandrim; Roger W C de Syllos; Hugo R K Lisboa; Glaucia S Tres; Jose E Tanus-Santos
Journal:  Atherosclerosis       Date:  2006-01-20       Impact factor: 5.162

8.  Effects of endothelial nitric oxide synthase tagSNPs haplotypes on nitrite levels in black subjects.

Authors:  Ingrid F Metzger; Marcelo R Luizon; Riccardo Lacchini; Marilia H Ishizawa; Jose E Tanus-Santos
Journal:  Nitric Oxide       Date:  2012-10-13       Impact factor: 4.427

9.  eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension.

Authors:  V C Sandrim; A C T Palei; M R Luizon; T C Izidoro-Toledo; R C Cavalli; J E Tanus-Santos
Journal:  Pharmacogenomics J       Date:  2009-08-25       Impact factor: 3.550

Review 10.  Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review.

Authors:  Juan P Casas; Gianpiero L Cavalleri; Leonelo E Bautista; Liam Smeeth; Steve E Humphries; Aroon D Hingorani
Journal:  Am J Epidemiol       Date:  2006-10-03       Impact factor: 4.897
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.